Formation and Thermal Stability of the ω-Phase in Ti–Nb and Ti–Mo Alloys Subjected to HPT

This paper discusses the features of ω-phase formation and its thermal stability depending on the phase composition, alloying element and the grain size of the initial microstructure of Ti–Nb and Ti–Mo alloys subjected to high-pressure torsion (HPT) deformation. In the case of two-phase Ti–3wt.% Nb and Ti–20wt.% Nb alloys with different volume fractions of α- and β-phases, a complete β→ω phase transformation and partial α→ω transformation were found. The dependence of the α→ω transformation on the concentration of the alloying element was determined: the greater content of Nb in the α-phase, the lower the amount of ω-phase that was formed from it. In the case of single-phase Ti–Mo alloys, it was found that the amount of ω-phase formed from the coarse-grained β-phase of the Ti–18wt.% Mo alloy was less than the amount of the ω-phase formed from the fine α′-martensite of the Ti–2wt.% Mo alloy. This was despite the fact that the ω-phase is easier to form from the β-phase than from the α- or α′-phase. It is possible that the grain size of the microstructure also affected the phase transformation, namely, the fine martensitic plates more easily gain deformation and overcome the critical shear stresses necessary for the phase transformation. It was also found that the thermal stability of the ω-phase in the Ti–Nb and Ti–Mo alloys increased with the increasing concentration of Nb or Mo.     

Prolonging Bacterial Viability in Biological Concrete: Coated Expanded Clay Particles

One of the biggest challenges in the development of a biological self-healing concrete is to ensure the long-term viability of bacteria that are embedded in the concrete. In the present study, a coated expanded clay (EC) is investigated for its potential use as a bacterial carrier in biological concrete. Eight different materials for coatings were selected considering cost, workability and accessibility in the construction industry. Long-term (56 days) viability analysis was conducted with a final evaluation of each coating performance. Our results indicate that healing efficiency in biological concrete specimens is strongly related to viable bacteria present in the healing agent. More viable bacteria-containing specimens exhibited a higher crack closure ratio. Our data suggest that the additional coating of EC particles improves long-term bacterial viability and, consequently, provides efficient crack healing in biological concrete.     

Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System

Urotensin-II (U-II) is a cyclic peptide now described as the most potent vasoconstrictor known. U-II binds to a specific G protein-coupled receptor, formerly the orphan receptor GPR14, now renamed urotensin receptor (UT receptor), and present in mammalian species. Palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt) is a new potent and specific antagonist of the human UT receptor. ACT-058362 antagonizes the specific binding of (125)I-labeled U-II on natural and recombinant cells carrying the human UT receptor with a high affinity in the low nanomolar range and a competitive mode of antagonism, revealed only with prolonged incubation times. ACT-058362 also inhibits U-II-induced calcium mobilization and mitogen-activated protein kinase phosphorylation. The binding inhibitory potency of ACT-058362 is more than 100-fold less on the rat than on the human UT receptor, which is reflected in a pD'(2) value of 5.2 for inhibiting contraction of isolated rat aortic rings induced by U-II. In functional assays of short incubation times, ACT-058362 behaves as an apparent noncompetitive inhibitor. In vivo, intravenous ACT-058362 prevents the no-reflow phenomenon, which follows renal artery clamping in rats, without decreasing blood pressure and prevents the subsequent development of acute renal failure and the histological consequences of ischemia. In conclusion, the in vivo efficacy of the specific UT receptor antagonist ACT-058362 reveals a role of endogenous U-II in renal ischemia. As a selective renal vasodilator, ACT-058362 may be effective in other renal diseases.     

Serum-Mediated Inhibition of Enzyme Replacement Therapy in Fabry Disease

Fabry disease (FD) is a progressive multisystemic disorder, treatable with recombinant enzyme replacement therapy (agalsidase). However, recent studies suggest an endogenous inhibition of agalsidase in patients with FD, as reported for other lysosomal storage diseases. To assess the clinical consequences of serum-mediated agalsidase inhibition in affected patients, we determined the agalsidase inhibition status of 168 patients (68 male) with FD and compared outcomes of inhibition-positive patients with those of inhibition-negative patients. The assessment included clinical events during time on agalsidase, determination of renal and cardiac function, and evaluation of FD-related symptoms. The frequency of serum-mediated agalsidase inhibition was 40% in agalsidase-treated males. Inhibition did not depend on the compound initially used (agalsidase-α or -β). Agalsidase inhibition was associated with higher lyso-globotriaosylceramide levels and worse disease severity scores in patients. Compared with agalsidase inhibition-negative men, agalsidase inhibition-positive men showed greater left ventricular mass (P=0.02) and substantially lower renal function (difference in eGFR of about –30 ml/min per 1.73 m²; P=0.04), which was confirmed by a longitudinal 5-year retrospective analysis. Additionally, affected patients presented more often with FD-typical symptoms, such as diarrhea, fatigue, and neuropathic pain, among others. Therefore, patients with poor clinical outcome on agalsidase should be tested for agalsidase inhibition. Future studies are warranted to determine if affected patients with FD benefit from acute reduction of anti-agalsidase antibodies or long-term immune modulation therapies to suppress agalsidase inhibition and to identify mechanisms that minimize antibody generation against agalsidase.     

Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivo

In this study, we investigated the in vitro and in vivo efficacy of patupilone (epothilone B, EPO906), a novel nontaxane microtubule stabilizing agent, in treatment of multiple myeloma (MM). Patupilone directly inhibited growth and survival of MM cells, including those resistant to conventional chemotherapies, such as the taxane paclitaxel. Patupilone induced G2M arrest of MM cells, with subsequent apoptosis. Interleukin-6 (IL-6) and insulin-like growth factor-1 (IGF-1), 2 known growth and survival factors for MM, did not protect MM.1S cells against patupilone-induced cell death. Proliferation of MM cells induced by adherence to bone marrow stromal cells (BMSCs) was also inhibited by patupilone and was paralleled by down-regulation of vascular endothelial growth factor (VEGF) secretion. Importantly, stimulation of cells from patients with MM, either with IL-6 or by adherence to BMSCs, enhanced the anti-proliferative and proapoptotic effects of patupilone. Moreover, patupilone was effective against MM cell lines that overexpress the MDR1/P-glycoprotein multidrug efflux pump. In addition, patupilone was effective in slowing tumor growth and prolonging median survival of mice that received orthotopical transplants with MM tumor cells. Taken together, these preclinical findings suggest that patupilone may be a safe and effective drug in the treatment of MM, providing the framework for clinical studies to improve patient outcome in MM.     

Excitatory cholecystokinin neurons of the midbrain integrate diverse temporal responses and drive auditory thalamic subdomains

The central nucleus of the inferior colliculus (ICC) integrates information about different features of sound and then distributes this information to thalamocortical circuits. However, the lack of clear definitions of circuit elements in the ICC has limited our understanding of the nature of these circuit transformations. Here, we combine virus-based genetic access with electrophysiological and optogenetic approaches to identify a large family of excitatory, cholecystokinin-expressing thalamic projection neurons in the ICC of the Mongolian gerbil. We show that these neurons form a distinct cell type, displaying uniform morphology and intrinsic firing features, and provide powerful, spatially restricted excitation exclusively to the ventral auditory thalamus. In vivo, these neurons consistently exhibit V-shaped receptive field properties but strikingly diverse temporal responses to sound. Our results indicate that temporal response diversity is maintained within this population of otherwise uniform cells in the ICC and then relayed to cortex through spatially restricted thalamic subdomains.

Before reaching the central nucleus of the inferior colliculus (ICC), auditory information is divided into parallel pathways that extract discrete acoustic features, including loudness, spectral information, and localization cues. Parallel inputs recombine in the ICC, which sends information via the ascending tectothalamic pathway to the primary auditory thalamus (ventral division of the medial geniculate body, vMGB) en route to the cortex. Despite their critical position at the nexus between the brainstem and the forebrain, the role of tectothalamic ICC neurons in integrating input features remains controversial. The lemniscal tectothalamic input is commonly regarded as a single phenotype, failing to account for the anatomical and physiological diversity of ICC neurons. Furthermore, it is unclear if the functional diversity of the ICC is a reflection of input patterns or a reflection of intrinsic properties.Many ICC neurons exhibit responses in vivo that closely resemble inputs from brainstem nuclei carrying spatial information (1–4), suggesting that the ICC collects and reroutes previously processed signals. However, in vivo recordings from guinea pig ICC have shown a continuum in the shape of frequency receptive fields, not the discrete categories that would be expected if responses were merely inherited (5). Although the receptive fields of ICC neurons can resemble those of lower nuclei, intracellular recordings revealed that a complex interplay between inhibitory and excitatory inputs to ICC neurons can also create receptive fields de novo (6, 7). These observations suggest that the ICC does not simply reroute inherited information but instead plays a more transformative role.Morphologically, ICC neurons consist of either cells with disk-shaped dendritic arbors flattened along the plane of the isofrequency laminae, or stellate cells with dendrites running across isofrequency laminae (8–11). However, dendritic morphology appears to correlate little with membrane properties and firing patterns in vitro (12–16) or with in vivo receptive fields (15–17), and it has remained unclear how much intrinsic membrane properties interact with synaptic inputs to shape auditory information.Here we identify an ICC neuron population that forms the major lemniscal excitatory projection to the MGB. These cholecystokinin (CCK) expressing neurons exhibit homogeneous intrinsic firing patterns and synaptic properties in vitro and V-shaped frequency receptive fields in vivo. However, even within this seemingly uniform population, we observed diverse temporal responses to tones in vivo, likely reflecting complexity in both intrinsic and extrinsic connectivity. Our results are consistent with a view of midbrain processing where individual cell types perform diverse processing tasks but mediate the convergence of this information onto specific target areas.     

Evaluation of borinic acids as new,fast hydrogen peroxide–responsive triggers

Hydrogen peroxide (H₂O₂) is responsible for numerous damages when overproduced, and its detection is crucial for a better understanding of H₂O₂-mediated signaling in physiological and pathological processes. For this purpose, various “off–on” small fluorescent probes relying on a boronate trigger have been prepared, and this design has also been involved in the development of H₂O₂-activated prodrugs or theranostic tools. However, this design suffers from slow kinetics, preventing activation by H₂O₂ with a short response time. Therefore, faster H₂O₂-reactive groups are awaited. To address this issue, we have successfully developed and characterized a prototypic borinic-based fluorescent probe containing a coumarin scaffold. We determined its in vitro kinetic constants toward H₂O₂-promoted oxidation. We measured 1.9 × 10⁴ m⁻¹⋅s⁻¹ as a second-order rate constant, which is 10,000-fold faster than its well-established boronic counterpart (1.8 m⁻¹⋅s⁻¹). This improved reactivity was also effective in a cellular context, rendering borinic acids an advantageous trigger for H₂O₂-mediated release of effectors such as fluorescent moieties.

Reactive oxygen species (ROS) are involved in various physiological processes. In particular, hydrogen peroxide (H₂O₂) plays a critical role in the regulation of numerous biological activities as a signaling molecule (1, 2). However, aberrant production or accumulation of H₂O₂ leads to oxidative stress conditions, which can cause lesions associated with aging, cancer (3), and several neurodegenerative diseases such as Alzheimer’s or Parkinson’s (4, 5). Differentiation of physiological or abnormal conditions is closely connected with slight changes in H₂O₂ levels. However, the generation and degradation of H₂O₂ are variable within different cellular compartments, and this small molecule is highly diffusive, rendering the capture of small H₂O₂ fluctuations and the study of its spatial and temporal dynamics difficult. Therefore, the development of selective and sensitive H₂O₂-reactive tools for applications in a biological context represents a challenge for a better understanding of H₂O₂-mediated signaling in physiological and pathological processes or the use of H₂O₂ activation for the release of biological effectors (6).Numerous strategies have been developed to implement H₂O₂-reactive molecular triggers, as exemplified by “off–on” small fluorescent probes. Such probes have attracted particular attention due to their easy implementation, high expected signal-to-noise ratio, and compatibility with standard equipment present in cellular biology research environments (7–9). Activation in such a context is triggered or modified by H₂O₂-mediated transformation of a suitable chemical species. Several approaches have been explored including probes based on arylsulfonyl ester perhydrolysis (10), oxidation of arylboronates (11), Baeyer–Villiger oxidation of diketones (12), Tamao oxidation of silanes (13), a tandem Payne–Dakin reaction (14) or a seleno-Mislow–Evans rearrangement (15). Among them, designs based on the boronate esters oxidation pioneered by Chang are the most explored, due to their remarkable stability, low toxicity profile, ease of preparation, and specificity toward H₂O₂, as illustrated in recent reviews (16–18). Upon reaction with H₂O₂, these compounds undergo an oxidative conversion into aryl borate esters that further hydrolyze into the corresponding phenols along with borate esters or boric acid (Scheme 1A). This conversion turns on probe fluorescence or activates drug release either directly or via the degradation of a self-immolative spacer. This chemospecific and biologically compatible reaction allowed, for instance, developing highly selective fluorescent probes for H₂O₂ imaging in cells (19–23). However, H₂O₂-triggered conversion of boronic acids to phenols is still not completely satisfactory in a biological context (24) since most of these probes have second-order reaction rate constants of 0.1 to 1.0 m⁻¹⋅s⁻¹ (14). In cells, H₂O₂ is present in the 1 to 100 nm concentration range in physiological conditions and could reach up to 100 μm under oxidative stress conditions (25). Therefore, most of the boronate-based systems need an incubation time longer than 30 min for activation at an H₂O₂ concentration of 100 μm. At such a time scale, H₂O₂ typically diffuses over a distance of 2 mm (evaluated as (D_H2O2τ)^0.5 with D_H2O2 = 1.7 × 10⁻⁹ m²⋅s⁻¹ from ref. 26 and τ = 30 min). Hence, to improve spatial resolution for H₂O₂ imaging, alternative H₂O₂ triggers with rapid reaction rates allowing real-time activation by H₂O₂ are still required.Open in a separate windowScheme 1.(A) Current boronic acid (R = H) or boronate (R,R = tetramethylethylene) as H₂O₂-responsive group releasing a hydroxyaryl as effector and a boric acid or a borate ester respectively. (B) This study: a borinic acid as H₂O₂-responsive group releasing a hydroxyaryl as effector and a boronic acid.To address this issue, we envisioned the use of borinic acids, structures in which one of the boron–oxygen bonds of the boronic acid is replaced by a boron–carbon bond. Due to these electronic modifications, borinic acids exhibit more electrophilic properties (27–30) compared to their boronic acid counterparts and could be more prone to rapid oxidation. These structures have been mainly exploited as catalysts in various reactions such as epoxide ring opening (31), hydrosilylation (32), transamidation (33), aldol reaction (34, 35), C–H activation (36, 37), selective monoalkylation, acylation and sulfonation of diols (38, 39), or regioselective glycosylation reactions (40–42). Surprisingly, the reactivity of these borinic species remains underexplored (43–45), probably due to their limited synthetic access (46–49). They were usually obtained through the addition of strong organometallic reagents (RLi/RMgBr) onto boron-based electrophiles such as trialkylborates, boron halides, diborane, or boronate esters. To date, a detailed study of the reactivity of borinic acids toward oxidation including reaction with H₂O₂ has not been reported and their use as triggers for the direct release of a probe or an effector has not been considered.Herein, we report the design, synthesis, and evaluation of a borinic-triggered prototypic probe prone to direct and rapid activation by the H₂O₂ molecule (Scheme 1B). We establish a detailed kinetic analysis of the H₂O₂-promoted oxidation of this borinic acid as well as a comparative study with its corresponding boronic analog. Furthermore, we demonstrate the shorter response time of the borinic trigger compared to the boronic trigger against H₂O₂-mediated oxidation in a cellular environment.     

Calorimetric study of 5-trimethylsilyl-2-norbornene,of its polymerization process and of poly(5-trimethylsilyl-2-norbornene) from 5 to 600 K at standard pressure

Thermodynamic properties of 5-trimethylsilyl-2-norbornene (TMSNB) and poly(5-trimethyl-silyl-2-norbornene) (PTMSNB), viz. the temperature dependence of the isobaric heat capacity C^o_p of the monomer between 10 and 330 K and of the polymer from 7 to 600 K, were studied by adiabatic vacuum and differential dynamic calorimetry. Temperature and enthalpy of monomer melting as well as parameters of glass transition and glassy state of the monomer and the polymer were determined. From the experimental data, the thermodynamic functions H°(T)-H°(0), S°(T) and G°(T)-H°(0) were calculated for TMSNB in the range of 0 to 330 K and for PTMSNB from 0 to 380 K. In a differential automatic calorimeter, the enthalpy of polymerization of TMSNB to PTMSNB in toluene solution was measured at T = 301 K and p = 101,325 kPa. Under similar physical conditions and in the same calorimeter, enthalpies of dissolution for the monomer and the polymer were estimated. The results were used to calculate the enthalpy, entropy and Gibbs function of bulk polymerization of TMSNB in the range of 0 to 380 K at standard pressure. The ceiling temperature of the polymerization process was also evaluated.